Adopt a Balanced Diet: Focus on nutrient-dense foods and controlled portions
In Apr26, Axsome has entered into an asset purchase agreement with Takeda for TAK-063 (balipodect), with an intention to develop it for treating schizophrenia & Tourette syndrome (P-III study-enabling activities for schizophrenia to begin in 2026) Total Revenue: $29.44B Founded Year: 1987 Total Employees: 17,000 Headquarters: California, United States Market Cap: $176.37B Stock Exchange: NASDAQ Gilead is a global biopharma company focused on antivirals and specialty therapeutics, with leadership in HIV, oncology, and liver diseases anchored by a strong antiviral franchise and an expanding oncology portfolio
Severe constipation : No bowel movement for more than 34 days despite home management, or inability to pass gas
This delayed gastric emptying contributes to reduced postprandial glucose excursions and increased feelings of fullness, though this effect may diminish over time with continued use
Front Bioeng Biotechnol
We forecast one to two GLP-1 launches annually starting in 2026, with the first oral entrant expected by 2027
